Patents by Inventor Miklos Nagy

Miklos Nagy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230048678
    Abstract: The invention relates to ICAN-derivative compounds having the general formula (I), wherein Q is selected from the group consisting of —NC, —NO2, —NO, —NHOH, —NCS and —NR1R2, for use as antifungal agents and gal preparations and pharmaceutical preparations for use in the treatment of a subject in need of antifungal medication.
    Type: Application
    Filed: December 23, 2020
    Publication date: February 16, 2023
    Inventors: Sándor KÉKI, Alexandra KISS, László MAJOROS, Miklós NAGY, Zsolt László NAGY, István PÓCSI, Dávid RÁCZ, Gábor SZEMÁN-NAGY, Zsuzsa MÁTHÉNÉ SZIGETI, László TÁLAS, Zoltán TÓTH, Miklós ZSUGA
  • Patent number: 5292505
    Abstract: Sulphated vinyl polymers such as sulphated polyvinylalcohol, sulphated copolymers of (meth)acrylic acid and vinylalcohol, and pharmaceutically acceptable salts thereof, have an antiviral effect against human immunodeficiency virus and may therefore be used as a therapeutic agent for treating retrovirus infections like AIDS and AIDS-related diseases. Their antiviral activity is apparently based on inhibition of virus adsorption; their inhibitory effect on giant cell formation is stronger than that of dextran sulphate.
    Type: Grant
    Filed: January 15, 1992
    Date of Patent: March 8, 1994
    Assignees: Stichting Rega VZW, Richter Gedeon Vegyeszeti Gyar RT
    Inventors: Masanori Baba, Erik D. A. De Clercq, Sandor Gorog, Miklos Low, Miklos Nagy, Sandorne Gyorgyi
  • Patent number: 5152978
    Abstract: Sulphated vinyl polymers such as sulphated polyvinylalcohol, sulphated copolymers of (meth)acrylic acid and vinylalcohol, and pharmaceutically acceptable salts thereof, have an antiviral effect against human immunodeficiency virus and may therefore be used as a therapeutic agent for treating retrovirus infections like AIDS and AIDS-related diseases. Their antiviral activity is apparently based on inhibition of virus adsorption; their inhibitory effect on giant cell formation is stronger than that of dextran sulphate.
    Type: Grant
    Filed: February 23, 1989
    Date of Patent: October 6, 1992
    Assignees: Stichting Rega VZW, Richter Gedeon Vegyeszeti Gyar R.T.
    Inventors: Masanori Baba, Erik D. A. De Clercq, Sandor Gorog, Miklos Low, Miklos Nagy, Sandorne Gyorgyi
  • Patent number: 4530964
    Abstract: The invention relates to new, pharmaceutically active copolymers with heparin-like activity, pharmaceutically acceptable salts thereof and a process for their preparation.
    Type: Grant
    Filed: March 24, 1983
    Date of Patent: July 23, 1985
    Assignee: Richter Gedeon Vegyeszeti Gyar R.T.
    Inventors: Raymund Machovich, Miklos Nagy, Judit Gyorgyi nee Edelenyi, Istvan Horvath, Miklos Low, Katalin Csomor, Egon Karpati, Laszlo Szporny, Lajos Kisfaludy
  • Patent number: 4258163
    Abstract: This invention relates to novel partially saponified polyvinyl acetates with a degree of hydrolysis of 30 to 65 mole % which might be considered as vinyl alcohol-vinyl acetate block copolymers. The invention relates further to the application of said novel block copolymers as a pore-forming additive used together with at least one known protective colloid in the homo- and copolymerization of vinyl compounds, primarily of vinyl chloride in a pure aqueous medium.
    Type: Grant
    Filed: May 23, 1979
    Date of Patent: March 24, 1981
    Assignee: Borsodi Vegyi Kombinat
    Inventors: Bela Mariasi, Laszlo Molnar, Janos Toth, Imre Gulya, Miklos Nagy, Ervin Wolfram, Miklos Zrinyi, Gaborne Kovacs, Laszlone Jaksity
  • Patent number: D297482
    Type: Grant
    Filed: December 23, 1985
    Date of Patent: September 6, 1988
    Inventor: Miklos Nagy